The global Generic Drugs market size was valued at USD 322540 million in 2022 and is forecast to a readjusted size of USD 550750 million by 2029 with a CAGR of 7.9% during review period.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares. North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
This report is a detailed and comprehensive analysis for global Generic Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Generic Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Generic Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Generic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Generic Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Generic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Generic Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Prescription
Non-Prescription Drugs
Hospital
Clinic
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Generic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Generic Drugs, with revenue, gross margin and global market share of Generic Drugs from 2018 to 2023.
Chapter 3, the Generic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Generic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Generic Drugs.
Chapter 13, to describe Generic Drugs research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Generic Drugs by Type
1.3.1 Overview: Global Generic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Generic Drugs Consumption Value Market Share by Type in 2022
1.3.3 Prescription
1.3.4 Non-Prescription Drugs
1.4 Global Generic Drugs Market by Application
1.4.1 Overview: Global Generic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Generic Drugs Market Size & Forecast
1.6 Global Generic Drugs Market Size and Forecast by Region
1.6.1 Global Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Generic Drugs Market Size by Region, (2018-2029)
1.6.3 North America Generic Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Generic Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Generic Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Generic Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Generic Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Generic Drugs Product and Solutions
2.1.4 Teva Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Recent Developments and Future Plans
2.2 Novartis - Sandoz
2.2.1 Novartis - Sandoz Details
2.2.2 Novartis - Sandoz Major Business
2.2.3 Novartis - Sandoz Generic Drugs Product and Solutions
2.2.4 Novartis - Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis - Sandoz Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Generic Drugs Product and Solutions
2.3.4 Mylan Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Generic Drugs Product and Solutions
2.4.4 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
2.5 Aspen
2.5.1 Aspen Details
2.5.2 Aspen Major Business
2.5.3 Aspen Generic Drugs Product and Solutions
2.5.4 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aspen Recent Developments and Future Plans
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Generic Drugs Product and Solutions
2.6.4 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Fresenius Kabi Recent Developments and Future Plans
2.7 Pfizer (Hospira)
2.7.1 Pfizer (Hospira) Details
2.7.2 Pfizer (Hospira) Major Business
2.7.3 Pfizer (Hospira) Generic Drugs Product and Solutions
2.7.4 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer (Hospira) Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Generic Drugs Product and Solutions
2.8.4 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Aurobindo
2.9.1 Aurobindo Details
2.9.2 Aurobindo Major Business
2.9.3 Aurobindo Generic Drugs Product and Solutions
2.9.4 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aurobindo Recent Developments and Future Plans
2.10 Lupin
2.10.1 Lupin Details
2.10.2 Lupin Major Business
2.10.3 Lupin Generic Drugs Product and Solutions
2.10.4 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lupin Recent Developments and Future Plans
2.11 Dr. Reddy's
2.11.1 Dr. Reddy's Details
2.11.2 Dr. Reddy's Major Business
2.11.3 Dr. Reddy's Generic Drugs Product and Solutions
2.11.4 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dr. Reddy's Recent Developments and Future Plans
2.12 Apotex
2.12.1 Apotex Details
2.12.2 Apotex Major Business
2.12.3 Apotex Generic Drugs Product and Solutions
2.12.4 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Apotex Recent Developments and Future Plans
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Generic Drugs Product and Solutions
2.13.4 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cipla Recent Developments and Future Plans
2.14 ENDO (Par Pharmaceutical)
2.14.1 ENDO (Par Pharmaceutical) Details
2.14.2 ENDO (Par Pharmaceutical) Major Business
2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Product and Solutions
2.14.4 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ENDO (Par Pharmaceutical) Recent Developments and Future Plans
2.15 Stada Arzneimittel
2.15.1 Stada Arzneimittel Details
2.15.2 Stada Arzneimittel Major Business
2.15.3 Stada Arzneimittel Generic Drugs Product and Solutions
2.15.4 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Stada Arzneimittel Recent Developments and Future Plans
2.16 Krka Group
2.16.1 Krka Group Details
2.16.2 Krka Group Major Business
2.16.3 Krka Group Generic Drugs Product and Solutions
2.16.4 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Krka Group Recent Developments and Future Plans
2.17 Nichi-Iko Pharmaceutical
2.17.1 Nichi-Iko Pharmaceutical Details
2.17.2 Nichi-Iko Pharmaceutical Major Business
2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Product and Solutions
2.17.4 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Nichi-Iko Pharmaceutical Recent Developments and Future Plans
2.18 Valeant
2.18.1 Valeant Details
2.18.2 Valeant Major Business
2.18.3 Valeant Generic Drugs Product and Solutions
2.18.4 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Valeant Recent Developments and Future Plans
2.19 Zydus Cadila
2.19.1 Zydus Cadila Details
2.19.2 Zydus Cadila Major Business
2.19.3 Zydus Cadila Generic Drugs Product and Solutions
2.19.4 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Zydus Cadila Recent Developments and Future Plans
2.20 Hikma
2.20.1 Hikma Details
2.20.2 Hikma Major Business
2.20.3 Hikma Generic Drugs Product and Solutions
2.20.4 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Hikma Recent Developments and Future Plans
2.21 Pharmaniaga Berhad
2.21.1 Pharmaniaga Berhad Details
2.21.2 Pharmaniaga Berhad Major Business
2.21.3 Pharmaniaga Berhad Generic Drugs Product and Solutions
2.21.4 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Pharmaniaga Berhad Recent Developments and Future Plans
2.22 Hovid Berhad
2.22.1 Hovid Berhad Details
2.22.2 Hovid Berhad Major Business
2.22.3 Hovid Berhad Generic Drugs Product and Solutions
2.22.4 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Hovid Berhad Recent Developments and Future Plans
2.23 Duopharma Biotech
2.23.1 Duopharma Biotech Details
2.23.2 Duopharma Biotech Major Business
2.23.3 Duopharma Biotech Generic Drugs Product and Solutions
2.23.4 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Duopharma Biotech Recent Developments and Future Plans
2.24 Kotra Pharma
2.24.1 Kotra Pharma Details
2.24.2 Kotra Pharma Major Business
2.24.3 Kotra Pharma Generic Drugs Product and Solutions
2.24.4 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Kotra Pharma Recent Developments and Future Plans
2.25 HOE Pharmaceutical
2.25.1 HOE Pharmaceutical Details
2.25.2 HOE Pharmaceutical Major Business
2.25.3 HOE Pharmaceutical Generic Drugs Product and Solutions
2.25.4 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 HOE Pharmaceutical Recent Developments and Future Plans
2.26 Y.S.P. Industries
2.26.1 Y.S.P. Industries Details
2.26.2 Y.S.P. Industries Major Business
2.26.3 Y.S.P. Industries Generic Drugs Product and Solutions
2.26.4 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Y.S.P. Industries Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Generic Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Generic Drugs by Company Revenue
3.2.2 Top 3 Generic Drugs Players Market Share in 2022
3.2.3 Top 6 Generic Drugs Players Market Share in 2022
3.3 Generic Drugs Market: Overall Company Footprint Analysis
3.3.1 Generic Drugs Market: Region Footprint
3.3.2 Generic Drugs Market: Company Product Type Footprint
3.3.3 Generic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Generic Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Generic Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Generic Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Generic Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Generic Drugs Consumption Value by Type (2018-2029)
6.2 North America Generic Drugs Consumption Value by Application (2018-2029)
6.3 North America Generic Drugs Market Size by Country
6.3.1 North America Generic Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Generic Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Generic Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Generic Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Generic Drugs Consumption Value by Type (2018-2029)
7.2 Europe Generic Drugs Consumption Value by Application (2018-2029)
7.3 Europe Generic Drugs Market Size by Country
7.3.1 Europe Generic Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Generic Drugs Market Size and Forecast (2018-2029)
7.3.3 France Generic Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Generic Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Generic Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Generic Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Generic Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Generic Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Generic Drugs Market Size by Region
8.3.1 Asia-Pacific Generic Drugs Consumption Value by Region (2018-2029)
8.3.2 China Generic Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Generic Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Generic Drugs Market Size and Forecast (2018-2029)
8.3.5 India Generic Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Generic Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Generic Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Generic Drugs Consumption Value by Type (2018-2029)
9.2 South America Generic Drugs Consumption Value by Application (2018-2029)
9.3 South America Generic Drugs Market Size by Country
9.3.1 South America Generic Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Generic Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Generic Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Generic Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Generic Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Generic Drugs Market Size by Country
10.3.1 Middle East & Africa Generic Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Generic Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Generic Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Generic Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Generic Drugs Market Drivers
11.2 Generic Drugs Market Restraints
11.3 Generic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Generic Drugs Industry Chain
12.2 Generic Drugs Upstream Analysis
12.3 Generic Drugs Midstream Analysis
12.4 Generic Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Generic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Generic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Generic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Generic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Teva Company Information, Head Office, and Major Competitors
Table 6. Teva Major Business
Table 7. Teva Generic Drugs Product and Solutions
Table 8. Teva Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Teva Recent Developments and Future Plans
Table 10. Novartis - Sandoz Company Information, Head Office, and Major Competitors
Table 11. Novartis - Sandoz Major Business
Table 12. Novartis - Sandoz Generic Drugs Product and Solutions
Table 13. Novartis - Sandoz Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis - Sandoz Recent Developments and Future Plans
Table 15. Mylan Company Information, Head Office, and Major Competitors
Table 16. Mylan Major Business
Table 17. Mylan Generic Drugs Product and Solutions
Table 18. Mylan Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Mylan Recent Developments and Future Plans
Table 20. Sun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 21. Sun Pharmaceutical Major Business
Table 22. Sun Pharmaceutical Generic Drugs Product and Solutions
Table 23. Sun Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sun Pharmaceutical Recent Developments and Future Plans
Table 25. Aspen Company Information, Head Office, and Major Competitors
Table 26. Aspen Major Business
Table 27. Aspen Generic Drugs Product and Solutions
Table 28. Aspen Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Aspen Recent Developments and Future Plans
Table 30. Fresenius Kabi Company Information, Head Office, and Major Competitors
Table 31. Fresenius Kabi Major Business
Table 32. Fresenius Kabi Generic Drugs Product and Solutions
Table 33. Fresenius Kabi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Fresenius Kabi Recent Developments and Future Plans
Table 35. Pfizer (Hospira) Company Information, Head Office, and Major Competitors
Table 36. Pfizer (Hospira) Major Business
Table 37. Pfizer (Hospira) Generic Drugs Product and Solutions
Table 38. Pfizer (Hospira) Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Pfizer (Hospira) Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Generic Drugs Product and Solutions
Table 43. Sanofi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. Aurobindo Company Information, Head Office, and Major Competitors
Table 46. Aurobindo Major Business
Table 47. Aurobindo Generic Drugs Product and Solutions
Table 48. Aurobindo Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aurobindo Recent Developments and Future Plans
Table 50. Lupin Company Information, Head Office, and Major Competitors
Table 51. Lupin Major Business
Table 52. Lupin Generic Drugs Product and Solutions
Table 53. Lupin Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Lupin Recent Developments and Future Plans
Table 55. Dr. Reddy's Company Information, Head Office, and Major Competitors
Table 56. Dr. Reddy's Major Business
Table 57. Dr. Reddy's Generic Drugs Product and Solutions
Table 58. Dr. Reddy's Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Dr. Reddy's Recent Developments and Future Plans
Table 60. Apotex Company Information, Head Office, and Major Competitors
Table 61. Apotex Major Business
Table 62. Apotex Generic Drugs Product and Solutions
Table 63. Apotex Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Apotex Recent Developments and Future Plans
Table 65. Cipla Company Information, Head Office, and Major Competitors
Table 66. Cipla Major Business
Table 67. Cipla Generic Drugs Product and Solutions
Table 68. Cipla Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Cipla Recent Developments and Future Plans
Table 70. ENDO (Par Pharmaceutical) Company Information, Head Office, and Major Competitors
Table 71. ENDO (Par Pharmaceutical) Major Business
Table 72. ENDO (Par Pharmaceutical) Generic Drugs Product and Solutions
Table 73. ENDO (Par Pharmaceutical) Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. ENDO (Par Pharmaceutical) Recent Developments and Future Plans
Table 75. Stada Arzneimittel Company Information, Head Office, and Major Competitors
Table 76. Stada Arzneimittel Major Business
Table 77. Stada Arzneimittel Generic Drugs Product and Solutions
Table 78. Stada Arzneimittel Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Stada Arzneimittel Recent Developments and Future Plans
Table 80. Krka Group Company Information, Head Office, and Major Competitors
Table 81. Krka Group Major Business
Table 82. Krka Group Generic Drugs Product and Solutions
Table 83. Krka Group Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Krka Group Recent Developments and Future Plans
Table 85. Nichi-Iko Pharmaceutical Company Information, Head Office, and Major Competitors
Table 86. Nichi-Iko Pharmaceutical Major Business
Table 87. Nichi-Iko Pharmaceutical Generic Drugs Product and Solutions
Table 88. Nichi-Iko Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nichi-Iko Pharmaceutical Recent Developments and Future Plans
Table 90. Valeant Company Information, Head Office, and Major Competitors
Table 91. Valeant Major Business
Table 92. Valeant Generic Drugs Product and Solutions
Table 93. Valeant Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Valeant Recent Developments and Future Plans
Table 95. Zydus Cadila Company Information, Head Office, and Major Competitors
Table 96. Zydus Cadila Major Business
Table 97. Zydus Cadila Generic Drugs Product and Solutions
Table 98. Zydus Cadila Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Zydus Cadila Recent Developments and Future Plans
Table 100. Hikma Company Information, Head Office, and Major Competitors
Table 101. Hikma Major Business
Table 102. Hikma Generic Drugs Product and Solutions
Table 103. Hikma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Hikma Recent Developments and Future Plans
Table 105. Pharmaniaga Berhad Company Information, Head Office, and Major Competitors
Table 106. Pharmaniaga Berhad Major Business
Table 107. Pharmaniaga Berhad Generic Drugs Product and Solutions
Table 108. Pharmaniaga Berhad Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Pharmaniaga Berhad Recent Developments and Future Plans
Table 110. Hovid Berhad Company Information, Head Office, and Major Competitors
Table 111. Hovid Berhad Major Business
Table 112. Hovid Berhad Generic Drugs Product and Solutions
Table 113. Hovid Berhad Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Hovid Berhad Recent Developments and Future Plans
Table 115. Duopharma Biotech Company Information, Head Office, and Major Competitors
Table 116. Duopharma Biotech Major Business
Table 117. Duopharma Biotech Generic Drugs Product and Solutions
Table 118. Duopharma Biotech Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Duopharma Biotech Recent Developments and Future Plans
Table 120. Kotra Pharma Company Information, Head Office, and Major Competitors
Table 121. Kotra Pharma Major Business
Table 122. Kotra Pharma Generic Drugs Product and Solutions
Table 123. Kotra Pharma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Kotra Pharma Recent Developments and Future Plans
Table 125. HOE Pharmaceutical Company Information, Head Office, and Major Competitors
Table 126. HOE Pharmaceutical Major Business
Table 127. HOE Pharmaceutical Generic Drugs Product and Solutions
Table 128. HOE Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. HOE Pharmaceutical Recent Developments and Future Plans
Table 130. Y.S.P. Industries Company Information, Head Office, and Major Competitors
Table 131. Y.S.P. Industries Major Business
Table 132. Y.S.P. Industries Generic Drugs Product and Solutions
Table 133. Y.S.P. Industries Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Y.S.P. Industries Recent Developments and Future Plans
Table 135. Global Generic Drugs Revenue (USD Million) by Players (2018-2023)
Table 136. Global Generic Drugs Revenue Share by Players (2018-2023)
Table 137. Breakdown of Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 138. Market Position of Players in Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 139. Head Office of Key Generic Drugs Players
Table 140. Generic Drugs Market: Company Product Type Footprint
Table 141. Generic Drugs Market: Company Product Application Footprint
Table 142. Generic Drugs New Market Entrants and Barriers to Market Entry
Table 143. Generic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 144. Global Generic Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 145. Global Generic Drugs Consumption Value Share by Type (2018-2023)
Table 146. Global Generic Drugs Consumption Value Forecast by Type (2024-2029)
Table 147. Global Generic Drugs Consumption Value by Application (2018-2023)
Table 148. Global Generic Drugs Consumption Value Forecast by Application (2024-2029)
Table 149. North America Generic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 150. North America Generic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 151. North America Generic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 152. North America Generic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 153. North America Generic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 154. North America Generic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 155. Europe Generic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 156. Europe Generic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 157. Europe Generic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 158. Europe Generic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 159. Europe Generic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 160. Europe Generic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 161. Asia-Pacific Generic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 162. Asia-Pacific Generic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 163. Asia-Pacific Generic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 164. Asia-Pacific Generic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 165. Asia-Pacific Generic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 166. Asia-Pacific Generic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 167. South America Generic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 168. South America Generic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 169. South America Generic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 170. South America Generic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 171. South America Generic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 172. South America Generic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 173. Middle East & Africa Generic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 174. Middle East & Africa Generic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 175. Middle East & Africa Generic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 176. Middle East & Africa Generic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 177. Middle East & Africa Generic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 178. Middle East & Africa Generic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 179. Generic Drugs Raw Material
Table 180. Key Suppliers of Generic Drugs Raw Materials
List of Figures
Figure 1. Generic Drugs Picture
Figure 2. Global Generic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Generic Drugs Consumption Value Market Share by Type in 2022
Figure 4. Prescription
Figure 5. Non-Prescription Drugs
Figure 6. Global Generic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Generic Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Generic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Generic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Generic Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Generic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Generic Drugs Consumption Value Market Share by Region in 2022
Figure 16. North America Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Generic Drugs Revenue Share by Players in 2022
Figure 22. Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Generic Drugs Market Share in 2022
Figure 24. Global Top 6 Players Generic Drugs Market Share in 2022
Figure 25. Global Generic Drugs Consumption Value Share by Type (2018-2023)
Figure 26. Global Generic Drugs Market Share Forecast by Type (2024-2029)
Figure 27. Global Generic Drugs Consumption Value Share by Application (2018-2023)
Figure 28. Global Generic Drugs Market Share Forecast by Application (2024-2029)
Figure 29. North America Generic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Generic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Generic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Generic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Generic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Generic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. France Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Generic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Generic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Generic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 46. China Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. India Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Generic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Generic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Generic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Generic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Generic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Generic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Generic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. Generic Drugs Market Drivers
Figure 64. Generic Drugs Market Restraints
Figure 65. Generic Drugs Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Generic Drugs in 2022
Figure 68. Manufacturing Process Analysis of Generic Drugs
Figure 69. Generic Drugs Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
